Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ODSH in Hospitalized COPD Exacerbations
2006-006378-32Phase 2Completed
- Sponsor
- ParinGenix
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dociparstat sodium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by ParinGenix. Primary endpoint: Incidence of treatment failure. Started Dec 2006; status: completed.
02
Drugs
dociparstat sodium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-006378-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006378-32.